Amanta Healthcare Share Price showed tremendous debut in Stock Market
New IPOs in the stock market always bring excitement for investors. Today, one such company made its first step in the market and gave a good return to the investors on the very first day. We are talking about the tremendous debut of Amanta Healthcare share price, in which investors were very happy.
Amanta Healthcare Share Price Listing gave a positive surprise
When trading started on 9 September, Amanta Healthcare share price was listed on NSE at ₹ 135 per share. This was about 7% higher than its IPO price of ₹ 126. The shares entered the BSE at ₹134, which was a premium of about 6.3%. Market experts were already estimating on the basis of grey market premium (GMP) that the listing would be around ₹135, and that is what happened. Meaning, the company debuted exactly as per the expectations of the market.
Journey of IPO Subscription and Allotment
The journey of this IPO started from 1 September, when the issue was opened for public. It closed on 3 September and the allotment was finalized on 4 September. Amanta Healthcare raised ₹126 crore through the IPO. The entire issue was a fresh issue in which 1 crore equity shares were issued. The lot size for retail investors was kept at 119 shares, which meant a minimum investment of ₹14,994 was required.
Investor response was worth watching. The total subscription of the IPO was 82.61 times. Retail quota was oversubscribed 54.98 times, but the biggest splash was made by Non-Institutional Investors who subscribed to the IPO 209.42 times. Qualified Institutional Buyers also showed great interest and subscribed 35.86 times. This clearly shows that investors from every category have put their faith in Amanta.
Amanta Healthcare Share Price Listing on NSE and BSE
On September 9, Amanta Healthcare share price made a solid entry into the Indian stock market. The shares were listed at ₹135 apiece on the NSE, which is around 7.14% higher than its IPO price of ₹126. Meanwhile, on the BSE, it opened at ₹134, giving a 6.35% premium to investors. This performance was very much in line with Street expectations, as the gray market premium (GMP) had already indicated a listing around the same level. With a GMP of ₹9 per share, analysts were expecting the stock to list at ₹135 – exactly what happened today.
Where will the IPO money be spent
The company had already made it clear that the money raised from the IPO will be used for expansion and new projects. The biggest part of this will be spent on setting up a new SteriPort manufacturing line at the Hariyala (Kheda) plant in Gujarat. A new SVP manufacturing line will also be built. Apart from capital expenditure, some money has also been kept for general corporate needs.
The lead manager of this IPO was Beeline Capital Advisors Pvt. Ltd. and MUFG Intime India Pvt. Ltd. took responsibility as the registrar.
The Story of Amanta Healthcare
Started in December 1994, Amanta Healthcare Limited is today a leading pharmaceutical company specializing in the manufacture of sterile liquid products. The company manufactures parenteral solutions that are packaged using advanced technology such as Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Molding (ISBM).
The company’s portfolio is very diverse. It manufactures IV fluids, diluents, ophthalmic solutions, respiratory care products as well as irrigation solutions, first-aid essentials and eye lubricants. All of these products strengthen the company’s strong position in the healthcare market.
What Amanta Healthcare Share Price Means for Investors
The strong debut of Amanta Healthcare share price is a positive sign. This shows that the market has full confidence in the company’s growth plans and vision. From retail to institutional, every investor category supported this IPO. This company is preparing itself for the future by understanding the demand of the healthcare sector.
The healthcare industry is growing rapidly in India, and in such a situation, the demand for players like Amanta Healthcare will increase even more. Therefore, today’s listing gain may not only be a short-term profit, but can also be the beginning of a long-term growth story.
Conclusion
Today’s listing has made one thing clear – investors of Amanta Healthcare share price have got a strong start. Oversubscription of IPO, premium listing and clear fund utilization plan shows that the company is serious and ready for the future. If it focuses on its expansion and product innovation, then the chances of shareholders getting good returns in the long term are very strong.
Disclaimer:
This article is for informational purposes only. Investing in stock market comes with risk. Do take advice from your financial advisor before taking investment decisions.
Also Read
Infy Share Price Rises Ahead of Infosys Buyback 2025 | Infosys Share Price News
